Pricing depends on pharmacy licensing, raw material sourcing, and regulatory compliance
They include an N-terminal 120160 residue extracellular domain (ECD) and a C-terminal transmembrane domain (TMD), both of which are important for peptide hormone binding and activation 2
Chadha, S
The MHRA has issued Drug Safety Updates highlighting this risk with various transdermal products
Solomon reports research grants from Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, Bristol Myers Squibb, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GlaxoSmithKline, Ionis, Eli Lilly, the National Institutes of Health/National Heart, Lung, and Blood Institute, Novartis, Novo Nordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, and YS2.AI
Do not rub the injection site as this can disperse the peptide away from the intended location